Related Experiment Video
Updated: Sep 17, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Primary Left Atrial Cardiopathy in Transthyretin Amyloidosis Cardiomyopathy by Multimodality Imaging: Implications
Benay Ozbay1, Corey Rearick1, Bharadwaj S Satyavolu1
1Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Insights
Thrombotic event risk in transthyretin amyloid cardiomyopathy (ATTR-CM) is linked to primary left atrial (LA) remodeling, not just atrial fibrillation or LA size. This LA cardiopathy is a key factor in ATTR-CM patients.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Cardiac Electrophysiology
Background:
- Transthyretin amyloid cardiomyopathy (ATTR-CM) is associated with a high risk of thrombotic events (TEs).
- Understanding the mechanisms driving TE risk in ATTR-CM is crucial for patient management.
Purpose of the Study:
- To investigate left atrial (LA) remodeling in ATTR-CM.
- To compare LA remodeling and TE risk in ATTR-CM versus other left ventricular hypertrophy (LVH) phenotypes.
- To identify independent predictors of TE in ATTR-CM.
Main Methods:
- Retrospective analysis of 405 subjects undergoing echocardiography, scintigraphy, and electrophoresis.
- Propensity score matching for age, sex, coronary artery disease, and diabetes.
- 5-year longitudinal follow-up for thrombotic events (TEs).
Main Results:
- ATTR-CM patients exhibited reduced left atrial reservoir strain (LASr) and increased LA stiffness compared to LVH controls.
- LASr in ATTR-CM was depressed independently of diastolic dysfunction and atrial fibrillation (AF).
- LASr and LA stiffness were independently associated with TEs in ATTR-CM, irrespective of CHA2DS2-VASc score or baseline AF.
Conclusions:
- Primary LA cardiopathy, characterized by impaired LASr and increased LA stiffness, is associated with TE risk in ATTR-CM.
- This association is independent of AF, CHA2DS2-VASc score, and LA dilatation.
- These findings differentiate TE risk factors in ATTR-CM from other LVH phenotypes.
Background:
Thrombotic event (TE) risk is high in transthyretin amyloid cardiomyopathy (ATTR-CM).
Objectives:
The authors sought to explore left atrial (LA) remodeling in ATTR-CM and its association with TE risk in comparison to other phenotypes of left ventricular hypertrophy (LVH).
Methods:
Subjects who underwent speckle tracking echocardiography, Tc-99m pyrophosphate scintigraphy, serum and urine immune electrophoresis, per registry protocol, were retrospectively identified (n = 405). Cardiac magnetic resonance and endomyocardial biopsy were used per clinical indication. Subjects with cardiac amyloidosis other than ATTR-CM were excluded, those with nonamyloid LVH served as controls. Propensity score matching was performed for age, sex, coronary artery disease, and diabetes. Longitudinal follow-up was performed over 5 years for TEs.
Results:
In all ATTR-CM (n =149) and LVH (n =165) in a propensity matched cohort (104:104), ATTR-CM subjects had decreased left atrial reservoir strain (LASr), smaller left atrial volume index, more intense late gadolinium hyperenhancement, and increased LA stiffness as compared to LVH. In ATTR-CM, LASr correlated poorly with E/e', was severely depressed regardless of the diastolic dysfunction grade (in those with sinus rhythm), and did not correlate with left atrial volume index, in contrast to the LVH group. LASr and LA stiffness were associated with ATTR-CM independently of diastolic dysfunction and atrial fibrillation (AF) (OR: 1.2 and OR: 1.9, respectively; P < 0.001 and P = 0.002). Furthermore, LASr and LA stiffness were independently associated with TEs (n = 20) during follow-up, regardless of CHA2DS2-VASc or prevalent AF at baseline, in ATTR-CM.
Conclusions:
Primary LA cardiopathy seems to be associated with TEs in ATTR-CM, independently of AF, CHA2DS2-VASc, and LA dilatation, unlike other LVH phenotypes.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies

